Hazlett, Burt & Watson’s Aptiv APTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37K Sell
828
-772
-48% -$39K 0.01% 507
2026
Q2
$96K Sell
1,600
-231
-13% -$14.1K 0.03% 361
2026
Q1
$126K Buy
1,831
+32
+2% +$2.47K 0.04% 311
2025
Q4
$139K Sell
1,799
-37
-2% -$2.97K 0.04% 297
2025
Q3
$158K Buy
1,836
+38
+2% +$2.87K 0.06% 257
2025
Q2
$122K Sell
1,798
-49
-3% -$3.03K 0.05% 252
2025
Q1
$110K Hold
1,847
– – 0.05% 262
2024
Q4
$110K Buy
1,847
+1,145
+163% +$70.1K 0.05% 266
2024
Q3
$50K Buy
702
+351
+100% +$24.5K 0.02% 351
2024
Q2
$25K Hold
351
– – 0.01% 418
2024
Q1
$28K Buy
+351
New +$28.3K 0.02% 396
2023
Q4
– Sell
-25
Closed -$3K – 678
2023
Q3
$3K Buy
25
+9
+56% +$930 ﹤0.01% 597
2023
Q2
$2K Buy
+16
New +$1.58K ﹤0.01% 608

Other funds holding APTV

Hazlett, Burt & Watson's APTV Position: Q3 2026 in Review

Hazlett, Burt & Watson reduced its Aptiv (APTV) stake by 48% in Q3 2026, selling an estimated $39K and leaving 828 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #507.

Hazlett, Burt & Watson first reported a position in APTV in Q2 2023 and has held it in 13 quarters since. The position peaked at $158K in Q3 2025. 269 funds tracked by Wall St. Rank hold APTV as of Q3 2026.

  • Hazlett, Burt & Watson held 828 shares of Aptiv worth $37K as of Q3 2026.
  • Hazlett, Burt & Watson sold 772 Aptiv shares in Q3 2026, an estimated $39K.
  • Aptiv made up 0.01% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #507 holding.
  • Hazlett, Burt & Watson first reported a position in Aptiv in Q2 2023 and has held it in 13 quarters since.
  • Hazlett, Burt & Watson's Aptiv position peaked at $158K in Q3 2025.
  • 269 funds tracked by Wall St. Rank held Aptiv as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.